All posts by: Michael Zand

About Michael Zand

First ‘off-the-shelf’ stem cell therapy gains central authorization in EU – The Pharma Letter

Continue reading

2018-03-23 NEWS

The Pharma Letter

First ‘off-the-shelf’ stem cell therapy gains central authorization in EU
The Pharma Letter
Japanese pharma company Takeda Pharmaceutical (TYO: 4502) and the Belgian biopharma that it is in the process of acquiring, TiGenix, achieved a notable milestone on Friday with the European Commission’s approval of Alofisel (darvadstrocel). It has been
Stem cell therapy approved in Europe to treat fistulizing Crohn’s diseaseHealio

all 3 news articles »

Continue reading

2018-03-23 NEWS

Everyday Health, Inc. (blog)

Early Results of International Stem Cell Trial for RRMS Show Reduced Relapses, Less Disability
Everyday Health, Inc. (blog)
Many people with relapsing-remitting multiple sclerosis (RRMS) do well on disease-modifying drugs. For those who don’t, interest in stem cell transplants — either to “reboot” the immune system or to repair damaged myelin — has been growing in recent

Continue reading

2018-03-23 NEWS

Fred Hutch News Service

Society for Immunotherapy of Cancer to honor Dr. Phil Greenberg
Fred Hutch News Service
On Thursday, the Society for Immunotherapy of Cancer announced Dr. Philip Greenberg as the 2018 recipient of the Richard V. Smalley, M.D., Memorial Award and Lectureship, the society’s highest honor. Greenberg is head of the Program in Immunology at

Continue reading

2018-03-23 NEWS

New Gene Therapy For Blindness Comes With Hefty Price Tag
WPSU
Earlier this week doctors in some hospitals began using gene therapy to treat a rare vision disorder that can lead to blindness. The procedure comes with a record-setting price tag — more than $400,000 per eye. Here & Now’s Meghna Chakrabarti learns

Continue reading

2018-03-23 NEWS

New Gene Therapy For Blindness Comes With Hefty Price Tag
NPR Illinois | 91.9 UIS
Earlier this week doctors in some hospitals began using gene therapy to treat a rare vision disorder that can lead to blindness. The procedure comes with a record-setting price tag — more than $400,000 per eye. Here & Now’s Meghna Chakrabarti learns

and more »

Continue reading

2018-03-23 NEWS

New Gene Therapy For Blindness Comes With Hefty Price Tag
NPR Illinois | 91.9 UIS
Earlier this week doctors in some hospitals began using gene therapy to treat a rare vision disorder that can lead to blindness. The procedure comes with a record-setting price tag — more than $400,000 per eye. Here & Now’s Meghna Chakrabarti learns

and more »

Continue reading

2018-03-23 NEWS

Seeker

Brewing Craft Beer With CRISPR, Not Hops
Seeker
Not only has the skyrocketing demand for hops affected the crop’s price — nearly doubling from $2.99 a pound in 2007 to $5.92 a pound in 2017 — but it’s also putting a strain on the environment. A thirsty hop field soaks up 50 pints of water for
Brewing hoppy beer without the hopsScience Daily
Beer made with gene-edited yeast provides hoppy taste without the hopsDigital Trends

all 105 news articles »